4.5 Article

Impact of the Combinations of Allergic Diseases on Myocardial Infarction and Mortality

出版社

ELSEVIER
DOI: 10.1016/j.jaip.2020.09.008

关键词

Asthma; Atopic dermatitis; Allergic rhinitis; Myocardial infarction; Mortality

资金

  1. Korea Medical Device Development Fund grant - Korea government (Ministry of Science and ICT) [HI20C1662]
  2. Korea National Research Foundation - Ministry of Education, Science and Technology [2020R1F1A106740]
  3. Korea Medical Device Development Fund grant - Korea government (Ministry of Trade, Industry and Energy) [HI20C1662]
  4. Korea Medical Device Development Fund grant - Korea government (Ministry of Health & Welfare, Republic of Korea) [HI20C1662]
  5. Korea Medical Device Development Fund grant - Korea government (Ministry of Food and Drug Safety) [HI20C1662]

向作者/读者索取更多资源

Patients with both atopic dermatitis and asthma have the highest risk of myocardial infarction and mortality among all combinations of allergic diseases.
BACKGROUND: Allergic rhinitis (AR), atopic dermatitis (AD), and asthma, each by itself, are known to be associated with a higher risk of cardiovascular disease. Each of these diseases often coexists with one another, but the effect of combined allergic diseases on the long-term risk of myocardial infarction (MI) and mortality remains unknown. OBJECTIVE: To evaluate the effects of various combinations of the allergic triad on the risk of MI and mortality. METHODS: Adult allergic disease patients without prior MI were enrolled from the nationwide health check-up data provided by the Korean National Health Insurance Service in 2009. The primary and secondary end points were all-cause death and MI. RESULTS: A total of 9,548,939 individuals older than 20 years were selected for analysis. The prevalence of allergic diseases was 13.9% for AR, 0.4% for AD, and 2.7% for asthma. During a median 8.2 years of follow-up, 105,659 MIs and 298,769 deaths occurred. All allergic diseases were associated with an increased risk of MI (AR, adjusted hazard ratio [HRadjust], 1.11, 95% CI, 1.10-1.13; AD, HRadjust, 1.14, 95% CI, 1.06-1.24; asthma, HRadjust, 1.37, 95% CI, 1.33-1.40), whereas mortality risk was increased only for patients with AD (HRadjust, 1.15; 95% CI, 1.10-1.20) or asthma (HRadjust, 1.41; 95% CI, 1.39-1.43). Among the combinations of allergic diseases, patients with both AD and asthma had the highest risk of mortality (HRadjust, 1.71; 95% CI, 1.46-2.00) and MI (HRadjust, 1.57; 95% CI, 1.15-2.16). The results were significant after adjusting for demographic characteristics, comorbidities, socioeconomic status, and lifestyle factors. CONCLUSIONS: Patients with both AD and asthma have the highest risk of MI and mortality among all allergic disease combinations. Physicians should evaluate combinations of allergic conditions in allergic disease patients and promptly assess and manage their future risk of MI and mortality. (C) 2020 American Academy of Allergy, Asthma & Immunology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据